Anticoagulation Prior to COVID-19 Infection Has No Impact on 6 Months Mortality: A Propensity Score-Matched Cohort Study

• Published in: Journal of clinical medicine Vol. 11; no. 2; p. 352
• Main Authors: Protasiewicz, Marcin, Reszka, Konrad, Kosowski, Wojciech, Adamik, Barbara, Bombala, Wojciech, Doroszko, Adrian, Gajecki, Damian, Gawryś, Jakub, Guziński, Maciej, Jedrzejczyk, Maria, Kaliszewski, Krzysztof, Kilis-Pstrusinska, Katarzyna, Konopska, Bogusława, Kopec, Agnieszka, Kujawa, Krzysztof, Langner, Anna, Larysz, Anna, Lis, Weronika, Pawlik-Sobecka, Lilla, Gorka-Dynysiewicz, Joanna, Rosiek-Biegus, Marta, Matera-Witkiewicz, Agnieszka, Matys, Tomasz, Pomorski, Michał, Sokolski, Mateusz, Sokołowski, Janusz, Tomasiewicz-Zapolska, Anna, Madziarska, Katarzyna, Jankowska, Ewa A
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 12.01.2022; MDPI
• Subjects: Anticoagulants; Clinical medicine; Cohort analysis; Coronaviruses; COVID-19; Fatalities; Mortality; Poland; COVID-19; SARS-CoV-2; 6 months outcome; thromboembolic complications; anticoagulation; mortality; morbidity

The coronavirus disease 2019 (COVID-19) shows high incidence of thromboembolic events in humans. In the present study, we aimed to evaluate if anticoagulation prior to COVID-19 infection may impact clinical profile, as well as mortality rate among patients hospitalized with COVID-19. The study was b...